Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VECTUS BIOSYSTEMS LIMITED Capital/Financing Update 2018

Jan 23, 2018

65993_rns_2018-01-23_25b03e0d-860e-42f6-adac-7add49fe6744.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [169 x 53] intentionally omitted <==

24 January 2018

Company Announcements Office Australian Securities Exchange

Release of Restricted Securities from Escrow

In accordance with ASX Listing Rule 3.10A, Vectus Biosystems Limited (ASX:VBS) advises that 8,521,387 fully paid ordinary shares and 100,000 Performance Rights, all of which were classified by ASX as restricted securities, are due for release from escrow on 23 February 2018. The Company will apply for quotation of these fully paid ordinary shares within 10 business days of this date, as required by ASX Listing Rule 2.8.2.

The Performance Rights were issued under the Vectus Employee Incentive Plan and expire on 23 February 2019 if not converted on that date into shares, after meeting the set performance condition. The conversion ratio of the Performance Rights into fully paid ordinary shares upon achievement of the relevant performance condition is one ordinary share for each Performance Right.

Vectus Biosystems Limited

Robert J Waring Company Secretary

VECTUS BIOSYSTEMS LIMITED ABN 54 117 526 137 3-11 Primrose Avenue, Rosebery, NSW 2018 Telephone: +61 2 9662 4144 Facsimile: +61 2 9697 0933 Website: www.vectusbiosystems.com.au